Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Helen Boucher

Transplant/Immunocompromised States · Tufts

View

Dr. Sara Dong

Transplant/Immunocompromised States · Boston Children's Hospital

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Keith Kaye

General ID · RU

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Kelly Dooley

Mycobacterial Disease · Vanderbilt

View

Dr. Erin Bonura

General ID · OHSU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.

    Aug 24, 2026DOI: 10.1093/cid/ciaf680Journal ArticleCID

    Written by: Amy Hirsch ShumakerAdarsh BhimrajRoger BedimoVincent Chi-Chung ChengKara W ChewEric S DaarDavid V GliddenRobert W ShaferPhyllis C TienLindsey R BadenKelly CawcuttKathleen ChiotosAmy L DzierbaErica J HardySteven JohnsonArthur Y KimChristine MacBrayneGreg S MartinNandita NadigMari M NakamuraCarlos R OliveiraJeffrey C PearsonLaura RileyShmuel ShohamPablo TebasZachary WillisJoshua WolfJennifer LovelessRebecca L MorganYngve Falck-YtterRajesh T Gandhi

    Find these authors on Roon

    AK

    Dr. Arthur Kim

    HIV/AIDS Medicine · MGH

    SS

    Dr. Shmuel Shoham

    Transplant/Immunocompromised States · Johns Hopkins

    Summary

    This article provides a focused update to the clinical practice guideline on the treatment and management of people with COVID-19, developed by the Infectious Diseases Society of America. The guideline panel presents 9 updated recommendations on the use of nirmatrelvir/ritonavir, remdesivir, and molnupiravir, in adults with mild to moderate COVID-19. The recommendations are based on evidence derived from a systematic literature review and adhere to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. The panel also provides a section on how to apply these recommendations, including an algorithm on the selection of antivirals.
    SSDr. Shmuel Shoham

    Dr. Shmuel Shoham

    Infectious Disease · Transplant/Immunocompromised States
    Johns Hopkins Medicine
    shmuel